Price target
129.830.00 0.00%
The 19 analysts offering 1 year price forecasts for MRNA have a max estimate of — and a min estimate of —.
Analyst rating
Based on 25 analysts giving stock ratings to MRNA in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
MRNA EPS for the last quarter is 0.55 USD despite the estimation of −0.99 USD. In the next quarter EPS is expected to reach −3.56 USD. Track more of Moderna, Inc. financials and stay on top of what is up with the company.
In the next quarter Moderna, Inc. revenue is expected to reach 93.26 M USD. Check out Moderna, Inc. revenue and earnings and make informed decisions.
According to analysts, MRNA price target is 129.83 USD with a max estimate of 310.00 USD and a min estimate of 59.00 USD. Check if this forecast comes true in a year, meanwhile keep track of the current situation with MRNA news and stock market news.
We've gathered opinions of 25 analysts rating MRNA stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.